Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Cachet Pharmaceutical (002462)
- 13.62
- -0.13-0.95%
Trading May 7 13:21 CST
3.97BMarket Cap38.47P/E (TTM)
13.77High13.60Low18.18KlotVolume13.75Open13.75Prev Close24.85MTurnover0.62%Turnover Ratio35.65P/E (Static)291.71MShares19.6952wk High0.91P/B3.97BFloat Cap12.6052wk Low15.13Limit Up291.47MShs Float83.34Historical High12.38Limit Down1.24%Range %3.57Historical Low0.17Dividend TTM13.66Avg Price10.59KlotAsk1.25%Div Yield TTM100Lot Size7.34KlotBid
Cachet Pharmaceutical (002462) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -15.09%3.97B | -18.71%19.53B | -21.80%14.46B | -24.45%9.7B | -37.15%4.68B | -19.93%24.02B | -15.14%18.49B | -13.70%12.84B | 10.17%7.44B | 14.40%30B |
| Operating revenue | -15.09%3.97B | -18.71%19.53B | -21.80%14.46B | -24.45%9.7B | -37.15%4.68B | -19.93%24.02B | -15.14%18.49B | -13.70%12.84B | 10.17%7.44B | 14.40%30B |
| Other operating revenue | ---- | -45.79%18.41M | ---- | -42.56%55.45M | ---- | --33.96M | ---- | 7.54%96.53M | ---- | --0 |
| Total operating cost | -14.26%3.89B | -19.44%18.92B | -22.16%14.06B | -25.07%9.42B | -37.82%4.53B | -19.76%23.48B | -14.97%18.07B | -13.36%12.58B | 10.22%7.29B | 14.81%29.27B |
| Operating cost | -14.03%3.75B | -18.53%18.28B | -21.80%13.55B | -24.65%9.09B | -37.91%4.36B | -19.94%22.43B | -14.52%17.33B | -12.95%12.06B | 11.73%7.02B | 16.20%28.02B |
| Operating tax surcharges | 1.24%7.13M | -30.78%34.14M | -40.03%24.09M | -44.61%15.86M | -36.52%7.04M | -3.68%49.31M | 5.33%40.16M | 15.60%28.64M | 13.43%11.09M | 11.79%51.2M |
| Operating expense | -13.98%64.48M | -49.59%261.56M | -40.84%234.73M | -47.74%147.1M | -49.77%74.96M | -28.42%518.89M | -33.10%396.77M | -30.08%281.46M | -23.83%149.24M | -13.17%724.91M |
| Administration expense | -19.99%53.78M | -25.33%271.72M | -8.79%193.1M | -12.13%128.25M | -9.65%67.22M | 11.42%363.9M | -7.23%211.7M | -6.62%145.95M | -7.80%74.4M | 2.51%326.6M |
| Financial expense | -46.36%12.34M | -36.98%74.36M | -33.61%59.53M | -25.44%46.7M | -28.13%23.01M | -17.98%118M | -22.39%89.67M | -21.70%62.63M | -23.13%32.01M | -19.61%143.87M |
| -Interest expense (Financial expense) | ---- | -36.06%82.6M | ---- | ---- | ---- | -16.88%129.18M | ---- | ---- | ---- | -11.35%155.42M |
| -Interest Income (Financial expense) | ---- | 38.29%-12M | ---- | ---- | ---- | 37.53%-19.44M | ---- | ---- | ---- | -38.75%-31.12M |
| Credit Impairment Loss | 61.86%-14.55M | -126.95%-259.16M | -94.38%-140.99M | -44.99%-76.29M | -187.81%-38.15M | -9.30%-114.19M | -35.56%-72.54M | -11.63%-52.61M | 21.50%-13.26M | -13.71%-104.47M |
| Asset Impairment Loss | -100.65%-2.68K | -29.91%-109.76M | -75.71%3.23M | -71.07%3.27M | -89.36%411.41K | 14.05%-84.49M | 148.14%13.29M | 154.36%11.29M | 356.89%3.87M | -316.20%-98.3M |
| Other net revenue | 82.39%-6.25M | -1,127.04%-326.09M | -191.80%-101.05M | -134.38%-42.35M | -1,327.77%-35.52M | 118.17%31.75M | 284.64%110.08M | 347.70%123.17M | 71.20%-2.49M | -120.50%-174.78M |
| Fair value change income | 65.28%-6.48K | -189.58%-32.08K | -260.00%-23.87K | -662.50%-33.57K | -180.65%-18.65K | 241.18%35.81K | 158.82%14.92K | 138.10%5.97K | 381.82%23.13K | 61.80%-25.36K |
| Invest income | 1,888.11%5.82M | 8,320.91%3.6M | 222.83%609.88K | -208.15%-462.36K | -235.67%-325.34K | 101.23%42.73K | 130.59%188.92K | 186.04%427.53K | 201.28%239.8K | -35.19%-3.47M |
| -Including: Investment income associates | ---- | -9.72%113.35K | ---- | ---- | ---- | 36.25%125.56K | ---- | ---- | ---- | 82.47%92.16K |
| Asset deal income | -199.05%-31.59K | -97.86%4.31M | -97.66%3.41M | -99.72%440.85K | -84.18%31.89K | 23,721.73%201.43M | 24,507.53%145.68M | 74,181.90%157.16M | 1,305.81%201.59K | -49.40%845.56K |
| Other revenue | -0.53%2.52M | 20.86%34.95M | 39.57%32.72M | 345.18%30.73M | -60.64%2.53M | -5.63%28.92M | 8.82%23.44M | -62.64%6.9M | -35.72%6.44M | -17.60%30.65M |
| Operating profit | -27.61%79.18M | -50.42%281.67M | -44.61%296.15M | -39.44%233.12M | -27.33%109.38M | 2.11%568.11M | 10.75%534.66M | 23.53%384.96M | 12.90%150.51M | -14.42%556.36M |
| Add:Non operating Income | -35.53%482.88K | -46.68%11.54M | 18.52%4.85M | -59.94%1.2M | -93.53%748.97K | 726.04%21.64M | 173.61%4.09M | 128.72%3M | 3,437.83%11.57M | 126.70%2.62M |
| Less:Non operating expense | -8.92%1.92M | -64.87%15.12M | 9.74%8.86M | -34.26%3.23M | 319.87%2.11M | 397.71%43.04M | 363.79%8.07M | 253.19%4.91M | -32.43%502.81K | -23.44%8.65M |
| Total profit | -28.03%77.74M | -49.13%278.09M | -44.95%292.14M | -39.67%231.09M | -33.15%108.02M | -0.66%546.7M | 9.98%530.68M | 22.95%383.06M | 21.58%161.58M | -14.00%550.33M |
| Less:Income tax cost | -20.92%26.01M | -23.31%176.38M | -40.74%100.65M | -47.39%68.58M | -25.63%32.89M | 28.67%229.99M | 38.27%169.85M | 63.03%130.35M | 25.27%44.22M | 1.22%178.75M |
| Net profit | -31.14%51.74M | -67.89%101.71M | -46.93%191.49M | -35.69%162.51M | -35.98%75.13M | -14.77%316.71M | 0.32%360.83M | 9.11%252.7M | 20.24%117.35M | -19.81%371.58M |
| Net profit from continuing operation | -31.14%51.74M | -67.89%101.71M | -46.93%191.49M | -35.69%162.51M | -35.98%75.13M | -14.77%316.71M | 0.32%360.83M | 9.11%252.7M | 20.24%117.35M | -19.81%371.58M |
| Less:Minority Profit | -52.89%13.65M | -106.10%-9.67M | -61.38%50.15M | -34.60%55.25M | -30.70%28.98M | 27.83%158.57M | 5.72%129.86M | 11.00%84.48M | 40.04%41.82M | -26.58%124.05M |
| Net profit of parent company owners | -17.48%38.08M | -29.57%111.38M | -38.81%141.33M | -36.24%107.26M | -38.90%46.15M | -36.12%158.14M | -2.49%230.97M | 8.19%168.22M | 11.51%75.53M | -15.92%247.54M |
| Earning per share | ||||||||||
| Basic earning per share | -18.75%0.13 | -29.63%0.38 | -39.24%0.48 | -36.21%0.37 | -38.46%0.16 | -37.21%0.54 | -2.47%0.79 | 9.43%0.58 | 11.97%0.26 | -15.69%0.86 |
| Diluted earning per share | -18.75%0.13 | -29.63%0.38 | -39.24%0.48 | -36.21%0.37 | -38.46%0.16 | -37.21%0.54 | -2.47%0.79 | 9.43%0.58 | 11.97%0.26 | -15.69%0.86 |
| Other composite income | ||||||||||
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%4.95M |
| Total composite income | -31.14%51.74M | -67.89%101.71M | -46.93%191.49M | -35.69%162.51M | -35.98%75.13M | -15.89%316.71M | 0.32%360.83M | 9.11%252.7M | 20.24%117.35M | -19.60%376.53M |
| Total composite income of parent company owners | -17.48%38.08M | -29.57%111.38M | -38.81%141.33M | -36.24%107.26M | -38.90%46.15M | -36.76%158.14M | -2.49%230.97M | 8.19%168.22M | 11.51%75.53M | -15.79%250.06M |
| Total composite income of minority owners | -52.89%13.65M | -106.10%-9.67M | -61.38%50.15M | -34.60%55.25M | -30.70%28.98M | 25.38%158.57M | 5.72%129.86M | 11.00%84.48M | 40.04%41.82M | -26.20%126.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm